Vaxcyte Inc’s recent filing unveils that its CHIEF EXECUTIVE OFFICER PICKERING GRANT unloaded Company’s shares for reported $1.13 million on Jun 24 ’24. In the deal valued at $75.64 per share,15,000 shares were sold. As a result of this transaction, PICKERING GRANT now holds 478,888 shares worth roughly $36.85 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, GUGGENHIME ANDREW sold 8,000 shares, generating $575,375 in total proceeds. Upon selling the shares at $71.92, the PRESIDENT AND CFO now owns 96,720 shares.
Before that, Gilbert Halley E sold 18,200 shares. Vaxcyte Inc shares valued at $1,328,600 were divested by the Director at a price of $73.00 per share. As a result of the transaction, Gilbert Halley E now holds 5,625 shares, worth roughly $0.43 million.
Mizuho initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 07, 2023; the price target was $69. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid April with a ‘”an Outperform”‘ rating. Needham also remained covering PCVX and reiterated its “Buy” recommendation on January 03, 2023. Guggenheim started covering the stock on December 15, 2022. It rated PCVX as “a Buy”.
Price Performance Review of PCVX
On Monday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock jump 1.89% to $76.94. Over the last five days, the stock has gained 1.53%. Vaxcyte Inc shares have risen nearly 22.52% since the year began. Nevertheless, the stocks have risen 58.61% over the past one year. While a 52-week high of $82.04 was reached on 02/28/24, a 52-week low of $44.20 was recorded on 01/05/24. SMA at 50 days reached $69.52, while 200 days put it at $62.38. A total of 0.96 million shares were traded, compared to the trading of 2.76 million shares in the previous session.
Levels Of Support And Resistance For PCVX Stock
The 24-hour chart illustrates a support level at 75.62, which if violated will result in even more drops to 74.29. On the upside, there is a resistance level at 77.86. A further resistance level may holdings at 78.77. The Relative Strength Index (RSI) on the 14-day chart is 60.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.66, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 31.57%. Stochastics%K at 72.60% indicates the stock is a holding.
The most recent change occurred on November 17, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $69 price target.
